AmSurg EVP Sells 1.5k Shares
The entire transaction, legally disclosed in a filing with Securities & Exchange Commission, was a total of $64,500.
Piper Jaffray Cos. has also increased Amsurg's target price from $36 to $42. Analysts with Deutsche Bank have raised their target price for the company from $39 to $45.
More Articles on Transactions and Valuation Issues:
Medical Facilities Corporation Announces October Dividend
What to Consider Before Selling an ASC
Key Observations on ASC Transactions in 2013
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.